Insider filing · DNTH
Simon Read
Director
profile →
Dianthus Therapeutics, Inc.
DNTH · Healthcare · 18 filings in 24 months
ticker →
Simon Read sold $327K of Dianthus Therapeutics (DNTH)
Executed Aug 19, disclosed Aug 19, the same day.
Value, as filed
$327K
2,778 sh × $117.55
Executed
Aug 19
the trade date, as filed
Disclosed
Aug 19
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SRSimon Read (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Dianthus Therapeutics, Inc. (DNTH). The largest single filing was $327K of DNTH (2,778 sh × $117.55, as filed), executed Aug 19.
The name
DNTHHealthcare · Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoi…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→